Chromothripsis in hematologic malignancies
Experimental Hematology · 2024-04 · 132 · 104172
DOI: 10.1016/j.exphem.2024.104172 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Experimental Hematology, 2024-04. Verfasst von Francisco Alejandro Lagunas-Rangel. Beteiligte Einrichtung: Department of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico…. Hauptthemen laut MEDLINE: Chromothripsis, Neoplasms, Hematologic Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Chromotrypsis, a phenomenon resulting from catastrophic mitotic errors and genomic instability, is defined by the occurrence of multiple DNA double-strand breaks in one or more chromosomes, subsequently subject to error-prone repair mechanisms. This unique process results in extensive rearrangements in the affected chromosomes, leading to loss of tumor suppressor function, the creation of fusion genes, and/or activation of oncogenes. The importance of chromothripsis in cancer, especially in the field of hematologic disorders, underscores the intricate interplay between genomic instability and the genesis of alterations that contribute to cancer. This accentuates the critical need to unravel these complex processes for the targeted development of specific therapeutic interventions. This review delves into the analysis of chromothripsis cases in various hematologic diseases, such as leukemia, lymphoma, and myeloma, with the aim of unveiling its profound impact on patient prognosis. Furthermore, the study explores the intricate molecular mechanisms underlying chromothripsis and investigates its consequences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico. Electronic address: francisco.lagunas@cinvestav.mx.
Zitieren
APA
Lagunas-Rangel, F. A. (2024). Chromothripsis in hematologic malignancies. Experimental Hematology, 132, 104172. https://doi.org/10.1016/j.exphem.2024.104172
Vancouver
Lagunas-Rangel FA. Chromothripsis in hematologic malignancies. Experimental Hematology. 2024;132:104172. doi:10.1016/j.exphem.2024.104172
BibTeX
@article{LagunasRangel2024,
author = {Lagunas-Rangel, Francisco Alejandro},
title = {Chromothripsis in hematologic malignancies},
journal = {Experimental Hematology},
year = {2024},
volume = {132},
pages = {104172},
doi = {10.1016/j.exphem.2024.104172}
}
EUVIMED